نتائج البحث - "Glucagon-Like Peptide-1 Receptor"

1

Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study

المؤلفون: Bo Lagerqvist, Thomas Nyström, Irene Santos-Pardo, Viveca Ritsinger, Anna Norhammar, Nils Witt

المصدر: International Journal of Cardiology. 330:23-29

مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, Incretin, Dipeptidyl peptidase-4 inhibitor, 030204 cardiovascular system & hematology, Lower risk, Glucagon-Like Peptide-1 Receptor, Coronary Restenosis, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Risk Factors, Internal medicine, Diabetes Mellitus, medicine, Humans, cardiovascular diseases, 030212 general & internal medicine, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, Sweden, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Hazard ratio, Percutaneous coronary intervention, Drug-Eluting Stents, Treatment Outcome, Pharmaceutical Preparations, Drug-eluting stent, Conventional PCI, Female, Cardiology and Cardiovascular Medicine, business, Mace, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c3f67e433bc2e0735963e162a4faa23Test
https://doi.org/10.1016/j.ijcard.2021.02.011Test

2

The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program

المؤلفون: Wayne Shaw, Hiddo J.L. Heerspink, Kenneth W. Mahaffey, Carolyn S.P. Lam, Gemma A. Figtree, Norman Rosenthal, Meg Jardine, Bruce Neal, Mikhail Kosiborod, Clare Arnott, Christopher P. Cannon, Brendon L. Neuen, Vlado Perkovic

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC), Cardiovascular Centre (CVC)

المصدر: International Journal of Cardiology, 318, 126-129. ELSEVIER IRELAND LTD

مصطلحات موضوعية: Cardiovascular disease, type 2 diabetes, medicine.medical_specialty, Type 2 diabetes, Disease, 030204 cardiovascular system & hematology, Placebo, Gastroenterology, Glucagon-Like Peptide-1 Receptor, 1117 Public Health and Health Services, 03 medical and health sciences, 0302 clinical medicine, GLP1 receptor agonist, Risk Factors, Internal medicine, Diabetes mellitus, SGLT2 inhibition, medicine, Humans, Hypoglycemic Agents, 030212 general & internal medicine, Canagliflozin, 1102 Cardiorespiratory Medicine and Haematology, Glucagon-like peptide 1 receptor, business.industry, Proportional hazards model, medicine.disease, Cardiovascular disease, Cardiovascular System & Hematology, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Heart Disease Risk Factors, type 2 diabetes, Cardiology and Cardiovascular Medicine, business, Body mass index, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0befa9facd7164e2dedf7e7c8da19d5Test
https://doi.org/10.1016/j.ijcard.2020.06.011Test

3

Remote ischemic conditioning protects against endothelial ischemia-reperfusion injury via a glucagon-like peptide-1 receptor-mediated mechanism in humans

المؤلفون: John Pernow, Peder Sörensson, Nawzad Saleh, Dinos Verouhis, Andrey Gourine, Magnus Settergren

المصدر: International Journal of Cardiology. 274:40-44

مصطلحات موضوعية: Adult, Male, Brachial Artery, medicine.drug_class, Ischemia, Myocardial Reperfusion Injury, 030204 cardiovascular system & hematology, Pharmacology, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, medicine.artery, medicine, Humans, cardiovascular diseases, 030212 general & internal medicine, Myocardial infarction, Brachial artery, Cardioprotection, business.industry, medicine.disease, Receptor antagonist, Glucagon-like peptide-1, Healthy Volunteers, Peptide Fragments, Vasodilation, Injections, Intravenous, Ischemic Preconditioning, Myocardial, Endothelium, Vascular, Cardiology and Cardiovascular Medicine, business, Reperfusion injury, Hormone

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63510611b590d4691a1a09165568a65dTest
https://doi.org/10.1016/j.ijcard.2018.09.061Test

4

Cardiologist's approach to the diabetic patient: No further delay for a paradigm shift

المؤلفون: Marco Ambrosetti, Domenico Cianflone, Rocco Grippo, Vincenzo Rizza, Lorenzo Cianfanelli, Carlo Gaspardone, Francesco Maranta

المصدر: International journal of cardiology. 338

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::652451b0667d909f360495096b474c35Test
https://pubmed.ncbi.nlm.nih.gov/34058289Test

5

Perspectives on cardiovascular effects of incretin-based drugs: From bedside to bench, return trip

المؤلفون: Antonio Ceriello, Michaela Luconi, Edoardo Mannucci, Giulia Cantini

المصدر: International Journal of Cardiology. 241:302-310

مصطلحات موضوعية: endocrine system, medicine.medical_specialty, Cardiotonic Agents, Glucagon-Like Peptides, Incretin, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Bioinformatics, Incretins, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Animals, Humans, Dipeptidyl peptidase-4, Dipeptidyl-Peptidase IV Inhibitors, Liraglutide, business.industry, Semaglutide, digestive, oral, and skin physiology, Type 2 Diabetes Mellitus, medicine.disease, Glucagon-like peptide-1, Treatment Outcome, Endocrinology, Diabetes Mellitus, Type 2, chemistry, Cardiovascular Diseases, Heart failure, Cardiology and Cardiovascular Medicine, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::308d213b6cf3f67c39b7c9616ae3c196Test
https://doi.org/10.1016/j.ijcard.2017.02.126Test

6

Exenatide in obese or overweight patients without diabetes: A systematic review and meta-analyses of randomized controlled trials

المؤلفون: Ting Xu, Xin Sun, Jianshu Li, Yun Li, Joey Sum-Wing Kwong, Qianrui Li, Ling Li, Kaiun Ren, Heyue Du, Haoming Tian, Sheyu Li, Na Su

المصدر: International Journal of Cardiology. 219:293-300

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec979cd27bdba9be765ad7dd4f6d4dcfTest
https://doi.org/10.1016/j.ijcard.2016.06.028Test

7

Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: A target to modulate cardiovascular risk?

المؤلفون: Gianluca Iacobellis, Massimiliano Marco Corsi Romanelli, Elena Dozio, Elena Vianello, Alexis Elias Malavazos, Gerd Schmitz, Lorenza Tacchini

المصدر: International journal of cardiology. 292

مصطلحات موضوعية: Adult, Male, endocrine system, medicine.medical_specialty, Adipose Tissue, White, Racemases and Epimerases, 030204 cardiovascular system & hematology, Glucagon-Like Peptide-1 Receptor, Transcriptome, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Adipose Tissue, Brown, Risk Factors, Internal medicine, Adipocyte, medicine, Humans, 030212 general & internal medicine, Receptor, Beta oxidation, Enoyl-CoA Hydratase, Glucagon-like peptide 1 receptor, Aged, Anthropometry, Microarray analysis techniques, business.industry, digestive, oral, and skin physiology, 3-Hydroxyacyl CoA Dehydrogenases, Lipid metabolism, Middle Aged, Acetyl-CoA C-Acyltransferase, Carbon-Carbon Double Bond Isomerases, Endocrinology, chemistry, Adipogenesis, Cardiovascular Diseases, Female, Cardiology and Cardiovascular Medicine, business, Pericardium, hormones, hormone substitutes, and hormone antagonists

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50343a4da08ffa1dc3da70ca286cd511Test
https://pubmed.ncbi.nlm.nih.gov/31023563Test

8

Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials

المؤلفون: Antonio Silverii, Francesco Andreozzi, Matteo Monami, Laura Pala, Edoardo Mannucci, S. Zannoni, Giorgio Sesti

المصدر: International journal of cardiology. 240

مصطلحات موضوعية: medicine.medical_specialty, 030204 cardiovascular system & hematology, metanalysis, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, chemistry.chemical_compound, cardiovascular events, 0302 clinical medicine, Internal medicine, medicine, Humans, Hypoglycemic Agents, 030212 general & internal medicine, Myocardial infarction, Stroke, Randomized Controlled Trials as Topic, glucagon-like peptide-1 receptor agonists, mortality, Liraglutide, business.industry, Venoms, Semaglutide, medicine.disease, Albiglutide, Endocrinology, Treatment Outcome, chemistry, Cardiovascular Diseases, Heart failure, Cardiology, Exenatide, Dulaglutide, Cardiology and Cardiovascular Medicine, business, Peptides, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f5f7903911202f2f8b8eada9d9566cTest
https://pubmed.ncbi.nlm.nih.gov/28501352Test

تنقيح النتائج